Lipofen (Fenofibrate) Patent Expiration, LOE Window & CMS Spending

Lipofen (Fenofibrate) by Cipher: Off-Patent Genericized (AB Competition), 10 AB generics, $195K 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCipher
FDA Application & PathwayN021612 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors10
2024 CMS Total Public Spend$195K
2024 Medicare Part D Spend$168K
2024 Medicaid Spend$28K
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 19.8% 2-yr change)